✦ LIBER ✦

Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: A randomised controlled 6-week trial

✍ Scribed by Helgo Magnussen; Henrik Watz; Anne Kirsten; Millie Wang; Heather Wray; Viktoria Samuelsson; John Mo; Richard Kay

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of an oral MMP-9 and -12 inhibit

✍ Ronald Dahl; Ingrid Titlestad; Ari Lindqvist; Pascal Wielders; Heather Wray; Mil 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 436 KB

Long-term safety and tolerability of apr

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A phase 1/2A Trial of STA 5326, an oral

✍ Robert Burakoff; Charles F. Barish; Dennis Riff; Ronald Pruitt; William Y. Chey; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

A 2-week multiple ascending dose, double

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Efficacy and safety of secukinumab, a fu

✍ McInnes, I. B.; Sieper, J.; Braun, J.; Emery, P.; van der Heijde, D.; Isaacs, J. 📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 471 KB